PACS, RIS, and CVIS | Europe | 2016 | Market Analysis
As Europe continues to grapple with the financial pressure and austerity measures introduced by the Eurozone crisis, revenue growth in the PACS, RIS, and CVIS market will increasingly be limited by continued budgetary constraints and growing preferences for emerging technologies.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PACS, RIS, and CVIS in Europe across a 10-year period.